| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4dac022280ec96f54c694eb427655932 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-17 |
| filingDate |
2000-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_798b96a313dd5d875b01a452f21ceda7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_616e9c2d3470f480ec8e5d744b92eec6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a40e390b2593e903d5cd7703aa0e6f77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64e1d64ab3eb0a2fa28b4abd7c75b42e |
| publicationDate |
2012-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2385857-C |
| titleOfInvention |
C peptide for improved preparation of insulin and insulin analogs |
| abstract |
The invention relates to a precursor of human insulin or an insulin analogue of the formula (I): Fus-B(1-30)-RDVP-Yn-A(1-21), whereby Fus is an optionally present fusion component of any sequence, B(1-30) is the B chain of human insulin, Y stands for an amino acid chain which ends with a C-terminal basic amino acid, n is 2 to 50 and indicates the length of the amino acid chain Y and A(1-21) is the A chain of human insulin. The A and/or the B chain can be modified by means of amino acid exchanges, deletions and/or additions. The invention also relates to a DNA coding therefor. The invention further relates to the production and the use of the precursor and the DNA as well as to a method for producing human insulin or an insulin analogue. |
| priorityDate |
1999-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |